News / Videos / Coronavirus Crisis / Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Name: Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid
Uploaded: 2021-06-22T17:52:48+05:30
Channel: Hindustan Times

coronavirus crisis

Published on Jun 22, 2021 05:52 PM IST

Share Via

Copy Link

Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday. The Hyderabad-based COVID vaccine manufacturing company had submitted data from the Phase III clinical trials of Covaxin to the Drugs Controller General of India (DCGI) over the weekend. Bharat Biotech's 'pre-submission' meeting with the World Health Organization (WHO) will take on Wednesday for the approval for Covaxin. Watch the full video for more details.

Copy

Whatsapp Twitter Facebook Linkedin

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Join Hindustan Times

Create free account and unlock exciting features like